WO2019223819A1 - Nutritional composition - Google Patents
Nutritional composition Download PDFInfo
- Publication number
- WO2019223819A1 WO2019223819A1 PCT/CZ2019/050023 CZ2019050023W WO2019223819A1 WO 2019223819 A1 WO2019223819 A1 WO 2019223819A1 CZ 2019050023 W CZ2019050023 W CZ 2019050023W WO 2019223819 A1 WO2019223819 A1 WO 2019223819A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nutritional composition
- composition according
- protein
- amino acids
- free amino
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 33
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 14
- 239000008103 glucose Substances 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- 150000001413 amino acids Chemical class 0.000 claims abstract description 12
- 229940057917 medium chain triglycerides Drugs 0.000 claims abstract description 10
- 210000003205 muscle Anatomy 0.000 claims abstract description 9
- 229930006000 Sucrose Natural products 0.000 claims abstract description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 8
- 239000005720 sucrose Substances 0.000 claims abstract description 8
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims abstract description 7
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 7
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 7
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 7
- 230000017423 tissue regeneration Effects 0.000 claims abstract description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 4
- 235000018102 proteins Nutrition 0.000 claims description 12
- 229940024606 amino acid Drugs 0.000 claims description 10
- 235000001014 amino acid Nutrition 0.000 claims description 10
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 5
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 5
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 5
- 229960000310 isoleucine Drugs 0.000 claims description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 5
- 239000004474 valine Substances 0.000 claims description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 4
- 229940000635 beta-alanine Drugs 0.000 claims description 4
- DROVUXYZTXCEBX-WCCKRBBISA-N (2s)-2-amino-5-(carbamoylamino)pentanoic acid;2-hydroxybutanedioic acid Chemical compound OC(=O)C(O)CC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=O DROVUXYZTXCEBX-WCCKRBBISA-N 0.000 claims description 3
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims description 3
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims description 3
- 229960002173 citrulline Drugs 0.000 claims description 3
- 235000013477 citrulline Nutrition 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 229960002743 glutamine Drugs 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 150000001735 carboxylic acids Chemical class 0.000 claims description 2
- -1 colourant Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 229960001031 glucose Drugs 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 229960003136 leucine Drugs 0.000 claims 2
- 229960004295 valine Drugs 0.000 claims 2
- 230000002641 glycemic effect Effects 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 3
- 235000015897 energy drink Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000021073 macronutrients Nutrition 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000021119 whey protein Nutrition 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000015943 Coeliac disease Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid ester group Chemical class C(CCCCCCCCCCC)(=O)O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000006609 metabolic stress Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/33—High-energy foods and drinks, sports drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0626—Isoleucine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0628—Leucine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/194—Triglycerides
- A23V2250/1944—Medium-chain triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
Definitions
- Fig. 1 depicts the course of glycaemic curves over time for medium Gl food, energy drink, coffee, and the present nutritional composition.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A nutritional composition comprising protein, free amino acids, medium chain triglycerides, glucose, isomaltulose, sucrose and maltodextrin, wherein the nutritional composition comprises from 2.5 to 10.5 wt. % of protein, 5.3 to 22.0 wt. % of free amino acids, 4.5 to 9.5 wt. % of medium chain triglycerides, 6.5 to 14.5 wt. % of glucose, 9.5 to 18.5 wt. % of sucrose, 27.5 to 35.5 wt. % of isomaltulose and 11.5 to 20.5 wt. % of maltodextrin relative to 100 wt. % of the total composition. The nutritional composition is usable in muscle tissue regeneration and/or glycaemia control.
Description
NUTRITIONAL COMPOSITION
Field of the Invention
The invention relates to a nutritional composition comprising macronutrients for optimizing energy intake of an individual under metabolic stress conditions.
Background of the Invention
Currently, the preparation of athletes not only for racing and training performances is energetically handled as based on the results of functional stress laboratory tests. It is a common phenomenon that basically regardless the time of day when the test is running, regardless the sport that the young athletes perform and independently of the meal they eat before the test, athletes enter energy deficits in the second half of the test. The change in the system of preparation of young athletes and the demands made on them regarding the performance have changed so dramatically that it is not possible to ensure a balanced intake and dispensing of basic macronutrients without a perfect and sophisticated energy replenishment throughout the day.
When solving this situation, however, all the assortment on the domestic and foreign markets is based on the assumption that the supplement must be financially interesting and thus very attractively offered in terms of marketing. So the amount of substances that are added to these energy supplements, including the energy of unnecessary micronutrients, is counterproductive, because instead of energizing in the right proportions, in time and use, they tend to burden the digestive tract and slow down the use of energy at the performance itself. From the biochemical point of view, it is necessary to streamline the absorption and metabolism of macronutrients and increase the energy potential of the cell, especially through metabolic pathways of glycolysis and aerobic phosphorylation.
The course of the glycaemic curve is measured as blood glucose (glycaemia) concentration over time, and both the onset and decrease and the slope of the glycaemic curve are important for energy intake optimization purposes. High Glycaemic Index (Gl) meals and energy drinks cause a rapid increase in glycaemia,
which is then compensated for by insulin secretion and rapid fall in glycaemia. The result is a short feeling of comfort within 30 minutes, followed by fatigue and hunger. Such a glycaemic curve is undesirable for optimal endurance sport performance and muscle tissue regeneration after exercise. Medium Gl foods induce a slower increase in glycaemia shortly after consumption (from 30 minutes to 1 hour), but this is followed by a rapid decrease in blood glucose, thus also unsuitable for optimal endurance sport performance and muscle recovery after exercise.
JPH 03251 154 discloses a nutritional composition for patients suffering from muscular dystrophy with a protein and free amino acids component of 10 to 90 wt. %, lipids of 0 to 15 wt. %, and saccharides of 10 to 80 wt. %. The protein component comprises a protein hydrolyzate of animal origin and leucine, isoleucine, valine and glutamine in an unspecified amount of individual amino acids, wherein the total free amino acid content is less than 35 wt. %. The lipid component may preferably be vegetable oil or medium chain triglycerides (MCT oil), and the carbohydrate component preferably includes glucose, maltose, sucrose, isomaltose, lactose, fiber, starch or dextrin. The declared contents of these components are relatively broad, thus requiring further research in narrowing the intervals, as well as exemplary compositions having only a high amount of other additives, such as vitamins, minerals, emulsifiers and the like.
Summary of the Invention
It is an object of the present invention to provide a nutritional composition comprising protein, free amino acids, medium chain triglycerides, glucose, isomaltulose (also known as pallatinose), sucrose and maltodextrin, comprising from 2.5 to 10.5 wt. % of protein, 5.3 to 22.0 wt. % of free amino acids, 4.5 to 9.5 wt. % of medium chain triglycerides, 6.5 to 14.5 wt. % of glucose, 9.5 to 18.5 wt. % of sucrose, 27.5 to 35.5 wt. % of isomaltulose and 1 1.5 to 20.5 wt. % of maltodextrin relative to 100 wt. % of the total composition.
Preferably, the nutritional composition comprises 3.0 to 10.0 wt. % of protein, 5.8 to 22.0 wt. % of free amino acids, 5.0 to 9.0 wt. % of medium chain triglycerides, 7.0 to 14.0 wt. % of glucose, 10.0 to 18.0 wt. % of sucrose, 28.0 to 35.0 wt. % of isomaltulose and 12.0 to 20.0 wt. % of maltodextrin relative to 100 wt. % of the total composition.
The protein in the nutritional composition preferably comprises the protein of plant or animal origin, for example rice or whey protein concentrate with low lipid content. However, depending on taste or other preferences, any protein may be used.
The free amino acids preferably include isoleucine, leucine, valine (these three also known as branched chain amino acids, BCAA), glutamine, beta-alanine and citrulline. Citrulline is preferably in the form of citrulline malate. Preferably, the nutritional composition comprises 0.5 to 3.0 wt. % of isoleucine, 1.0 to 5.0 wt. % of leucine, 0.5 to 3.0 wt. % of valine, 1.5 to 4.0 wt. % of glutamine, 1.0 to 4.0 wt. % of beta-alanine and 0.8 to 3.0 wt. % of citrulline malate relative to 100 wt. % of the total composition. Medium chain triglycerides (also known as MCT oil) preferably include esters of glycerol and carboxylic acids of 6, 8, 10 and 12 carbons, for example caproic, caprylic, capric or lauric acids.
Further, the nutritional composition preferably comprises at least one aroma, flavour, colourant, sweetener and/or filler. Useful aromas and flavours include, but are not limited to, chocolate, cocoa, strawberry, raspberry, forest fruit, exotic fruit, and the like. For example, stevia may be used as a sweetener, and the filler may preferably be arabic, xanthan or guar gum.
The nutritional composition is preferably in a liquid, gel, solid or powder form. The nutritional composition can be dissolved in water or other liquid for the preparation of the beverage.
The present invention further provides a use of the nutritional composition as defined above for muscle tissue regeneration and/or glycaemia control.
The claimed nutritional composition will allow an individual to easily replenish their energy during a busy day or before difficult exercise, and the formulation used will result in a stable blood glucose level and eliminate extreme fluctuations caused by the current diet thereby burdening the digestive system. Due to the gradual release of glucose into the blood, it will provide the necessary support during a stressful situation without the feeling of full stomach and subsequent exhaustion, which is usually caused by a decrease in blood plasma glucose. The gradual release of the components of the composition will delay sports fatigue as it slows down the loss of muscle glycogen, which is an immediate source of energy for the muscles. As a result, exhaustion and
pain in muscle tissue are delayed. Products containing this nutritional composition can be used as a substitute for a heavy and irregular diet over the day, which suppresses and reduces both concentration and performance.
In Fig. 1 , it can be seen that the glycaemic curve of the present nutritional composition is maintained between 5.0 and 6.5 mmol/L of Glu over 90 minutes, which is the lowest plasma glucose fluctuation from the comparative items (medium Gl meal, energy drink, coffee, and nutritional composition).
Description of the Drawings The invention will be explained in more detail with reference to the drawings, in which: • Fig. 1 depicts the course of glycaemic curves over time for medium Gl food, energy drink, coffee, and the present nutritional composition.
Exemplary embodiments Example 1 : Nutritional composition containing whey protein
Industrial Applicability
The industrial applicability of the nutritional composition is mainly for athletes, for muscle tissue regeneration after exercise and for regulating the glycaemic curve during the day. The nutritional composition is also intended for groups of people with special dietary needs and requirements such as people diagnosed with coeliac disease, people with food allergies, people with lactose intolerance, vegetarians and vegans, pregnant and nursing women.
Claims
1. Nutritional composition comprising protein, free amino acids, medium chain triglycerides, glucose, isomaltulose, sucrose and maltodextrin, characterized in that it comprises from 2.5 to 10.5 wt. % of protein, 5.3 to 22.0 wt. % of free amino acids, 4.5 to 9.5 wt. % of medium chain triglycerides, 6.5 to 14.5 wt. % of glucose, 9.5 to 18.5 wt. % of sucrose, 27.5 to 35.5 wt. % of isomaltulose and 1 1.5 to 20.5 wt. % of maltodextrin relative to 100 wt. % of the total composition.
2. Nutritional composition according to claim 1 , characterized in that the protein includes a protein of plant or animal origin.
3. Nutritional composition according to claim 1 , characterized in that the free amino acids include isoleucine, leucine, valine, glutamine, beta-alanine and citrulline.
4. Nutritional composition according to claim 3, characterized in that it comprises 0.5 to 3.0 wt. % of isoleucine, 1 .0 to 5.0 wt. % of leucine, 0.5 to 3.0 wt. % of valine, 1.5 to 4.0 wt. % of glutamine, 1.0 to 4.0 wt. % of beta-alanine and 0.8 to 3.0 wt. % of citrulline malate relative to 100 wt. % of the total composition.
5. Nutritional composition according to claim 1 , characterized in that medium chain triglycerides include esters of glycerol and carboxylic acids of 6, 8, 10 and 12 carbons.
6. Nutritional composition according to any of the preceding claims, characterized in that it further comprises at least one aroma, flavour, colourant, sweetener and/or filler.
7. Nutritional composition according to any of the preceding claims, characterized in that it is in a liquid, gel, solid or powder form.
8. Use of the nutritional composition according to any of the preceding claims in muscle tissue regeneration.
9. Use of the nutritional composition according to any of the preceding claims in glycaemia control.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ2018-242A CZ308120B6 (en) | 2018-05-25 | 2018-05-25 | Nutritional composition |
| CZPV2018-242 | 2018-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019223819A1 true WO2019223819A1 (en) | 2019-11-28 |
Family
ID=67587376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CZ2019/050023 WO2019223819A1 (en) | 2018-05-25 | 2019-05-24 | Nutritional composition |
Country Status (2)
| Country | Link |
|---|---|
| CZ (1) | CZ308120B6 (en) |
| WO (1) | WO2019223819A1 (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010041187A1 (en) * | 1998-10-20 | 2001-11-15 | Carl W Hastings | Performance-enhancing dietary supplement |
| WO2007108827A1 (en) * | 2006-03-23 | 2007-09-27 | Nestec S.A. | High-calorie nutritional supplement |
| US8703719B1 (en) * | 2009-05-18 | 2014-04-22 | Bio-Engineered Supplements And Nutrition, Inc. | Method and composition for improved muscle performance |
| WO2016029074A1 (en) * | 2014-08-22 | 2016-02-25 | Abbott Laboratories | Nutritional beverage containing rice protein |
| WO2016044167A1 (en) * | 2014-09-15 | 2016-03-24 | Abbott Laboratories | Methods for increasing muscle strength and mobility in subjects experiencing significant physical inactivity using gamma linolenic acid |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO962728A (en) * | 1996-06-27 | 1997-11-17 | Jan Oxholm Gordeladze | Energy drink |
| GB0612671D0 (en) * | 2006-06-27 | 2006-08-09 | Shs Int Ltd | Nutritional formulation |
| EP2098126A1 (en) * | 2008-03-03 | 2009-09-09 | Nestec S.A. | Carbohydrate Bar |
| RU2013151680A (en) * | 2011-04-21 | 2015-05-27 | Нестек С.А. | NUTRITIONAL COMPOSITIONS FOR IMPROVEMENT OF PERFORMANCE, WAYS OF THEIR OBTAINING AND USE |
| CZ32013U1 (en) * | 2018-05-25 | 2018-08-28 | Euro Enterprise Development s.r.o. | A nutritional composition |
-
2018
- 2018-05-25 CZ CZ2018-242A patent/CZ308120B6/en not_active IP Right Cessation
-
2019
- 2019-05-24 WO PCT/CZ2019/050023 patent/WO2019223819A1/en active Application Filing
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010041187A1 (en) * | 1998-10-20 | 2001-11-15 | Carl W Hastings | Performance-enhancing dietary supplement |
| WO2007108827A1 (en) * | 2006-03-23 | 2007-09-27 | Nestec S.A. | High-calorie nutritional supplement |
| US8703719B1 (en) * | 2009-05-18 | 2014-04-22 | Bio-Engineered Supplements And Nutrition, Inc. | Method and composition for improved muscle performance |
| WO2016029074A1 (en) * | 2014-08-22 | 2016-02-25 | Abbott Laboratories | Nutritional beverage containing rice protein |
| WO2016044167A1 (en) * | 2014-09-15 | 2016-03-24 | Abbott Laboratories | Methods for increasing muscle strength and mobility in subjects experiencing significant physical inactivity using gamma linolenic acid |
Also Published As
| Publication number | Publication date |
|---|---|
| CZ2018242A3 (en) | 2020-01-15 |
| CZ308120B6 (en) | 2020-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1737304B1 (en) | Liquid concentrated formula | |
| US20060105938A1 (en) | Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein | |
| CN102791140A (en) | Cocoa-based exercise recovery beverages | |
| CN104544432A (en) | Samara oil compound protein solid beverage and method for preparing same | |
| RU2732456C1 (en) | Specialized food product for correction of food status disorders | |
| EP2158918A1 (en) | Method for reducing postprandial glucose levels with a composition of whey protein | |
| US20160213040A1 (en) | Nutritional composition for pregnant women with a beneficial glucose and insulin profile | |
| WO2002052954A2 (en) | Nutritional composition for a bone condition | |
| MX2011010925A (en) | High fiber nutritional emulsions for blood glucose control. | |
| WO2022270065A1 (en) | Nutritional composition | |
| EP2708146A1 (en) | Nutritional composition for pregnant women with a beneficial glucose and insulin profile | |
| JP2009256366A (en) | Lipid metabolism-improving agent | |
| CN108497250A (en) | A kind of the lactalbumin sports drink and production technology of MCT reinforcings | |
| JP2012523841A (en) | High fiber nutrition emulsion with glycerin | |
| CZ32013U1 (en) | A nutritional composition | |
| WO2019223819A1 (en) | Nutritional composition | |
| CZ32011U1 (en) | A nutritional composition | |
| WO2019223818A1 (en) | Nutritional composition | |
| CZ32012U1 (en) | A nutritional composition | |
| CZ2018243A3 (en) | Nutritional composition | |
| JP2022056677A (en) | Compositions for preventing or treating anemia, composition for preventing increase or decrease in blood hemoglobin concentration, and composition for preventing increase or decrease in red blood cell count in blood | |
| JP2023069186A (en) | Nutritive composition, manufacturing method of nutritive composition, and evaluation method of bioavailability of copper in nutritive composition | |
| Mix | FIT Food™ Lean Whey | |
| Mix | FIT Food™ Whey |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19752418 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 19752418 Country of ref document: EP Kind code of ref document: A1 |